IP Library Granted Patent US 10,201,383
Granted Patent B2
US 10,201,383 · App. 14/216,849 · Granted Feb 12, 2019

Methods for tissue ablation measurement and control and devices thereof

Inventors: Wayne Ogata (San Ramon, CA); Xiang Ian Gu (Foster City, CA); Steven Meyer (Oakland, CA); Alireza Yavari (Sunnyvale, CA)
Assignee: Retrovascular, Inc.
A61B18/1233A61B18/1492A61B2017/00057A61B2017/00106A61B2018/00642A61B2018/00678A61B2018/00702A61B2018/00708A61B2018/00779A61B2018/00785A61B2018/00791A61B2018/00827A61B2018/00869A61B2018/00875A61B2018/00892
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,201,383
App. No.
14/216,849
Granted
Feb 12, 2019
Kind
B2
Abstract

An apparatus comprises a first longitudinal member and a second longitudinal member configured to be located near a tissue region. An energy source is coupled to first longitudinal member and second longitudinal member. A measuring device is configured to measure at least one characteristic of the tissue region. An energy controller is coupled to the energy source and the measuring device. The energy controller includes a processor coupled to a memory and configured to execute programmed instructions stored in the memory, comprising initiating a delivery of energy to the tissue region from the energy source. One or more items of data are received from the measuring device based on the delivery of energy to the tissue region. The delivery of energy to the tissue region is adjusted based on the one or more items of data.

Claims (48)

1. An apparatus comprising:

a first longitudinal member and a second longitudinal member configured to be located near a tissue region;

an energy source coupled to the first longitudinal member and the second longitudinal member;

a measuring device configured to measure at least one characteristic of the tissue region; and

an energy controller coupled to the energy source and the measuring device, the energy controller comprising a processor coupled to a memory and configured to execute programmed instructions stored in the memory, comprising:

initiating a delivery of energy to the tissue region from the energy source;

receiving one or more items of data from the measuring device based on the delivery of energy to the tissue region;

determining a pre-plasma phase, a plasma phase, and a channel phase in the tissue region based on the one or more items of data throughout formation of a channel in the tissue region; and

adjusting the delivery of energy to the tissue region based on the determined pre-plasma phase, plasma phase, and channel phase states throughout the formation of the channel in the tissue region.

2. The apparatus as set forth in claim 1 wherein the processor is further configured to execute programmed instructions stored in the memory further comprising:

comparing the one or more items of data with one or more parameters related to the one or more items of data; and

adjusting the delivery of energy to the tissue region based on the comparison.

3. The apparatus as set forth in claim 2 wherein the one or more parameters comprise one or more tissue ablation waveforms.

4. The apparatus as set forth in claim 2 wherein the one or more parameters are input by a user.

5. The apparatus as set forth in claim 1 wherein the energy source comprises a radio frequency energy source.

6. The apparatus as set forth in claim 1 wherein the measuring device measures an electrical characteristic of the tissue region.

7. The apparatus as set forth in claim 6 wherein the electrical characteristic comprises one or more of current, voltage, forward power, reverse power, phase angle, or impedance.

8. The apparatus as set forth in claim 1 wherein the measuring device measures a physiological characteristic of the tissue region.

9. The apparatus as set forth in claim 8 wherein the physiological characteristic comprises one or more or of an impedance, a temperature, a pressure, a composition, or an elasticity.

10. The apparatus as set forth in claim 1 wherein the measuring device measures a visual characteristic of the tissue region.

11. The apparatus as set forth in claim 10 wherein the measuring device comprises one of intravascular ultrasound, optical coherence tomography, optical coherence reflectometry, or angiography.

12. The apparatus as set forth in claim 1 wherein the adjusting the delivery of energy to the tissue region further comprises terminating the energy delivery when the one or more items of data from the measuring device exceed a threshold value.

13. The apparatus as set forth in claim 1 wherein the one or more items of data comprises a voltage waveform and wherein the pre-plasma phase is indicated by a peak voltage measurement of the voltage waveform, the plasma phase is indicated by a decrease in the voltage measurement of the voltage waveform, and the channel phase is indicated by a further decrease in the voltage measurement of the voltage waveform.

14. The apparatus as set forth in claim 1 wherein the one or more items of data comprises a current waveform and wherein the pre-plasma phase is indicated by a minimum current measurement of the waveform, the plasma phase is indicated by an increase in the current measurement of the current waveform, and the channel phase is indicated by a further increase in the current measurement of the current waveform.

15. The apparatus as set forth in claim 1 wherein the adjusting the delivery of energy to the tissue region further comprises adjusting the delivery of energy to minimize treatment time.

16. The apparatus as set forth in claim 1 wherein the adjusting the delivery of energy to the tissue region further comprises adjusting the delivery of energy to minimize thermal effects on the tissue region.

17. A method comprising:

initiating, by a tissue ablation monitoring computing device, a delivery of energy from an energy source to a tissue region through a first longitudinal member and a second longitudinal member located near the tissue region;

receiving, by the tissue ablation monitoring computing device, one or more items of data from a measuring device based on the delivery of energy to the tissue region;

determining, by the tissue ablation monitoring computing device, a pre-plasma phase, a plasma phase, and a channel phase in the tissue region based on the one or more items of data throughout formation of a channel in the tissue region; and

adjusting, by the tissue ablation monitoring computing device, the delivery of energy to the tissue region based on the determined pre-plasma phase, plasma phase, and channel phase states throughout the formation of the channel in the tissue region.

18. The method as set forth in claim 17 further comprising:

comparing, by the tissue ablation monitoring computing device, the one or more items of data with one or more parameters related to the one or more items of data; and

adjusting, by the tissue ablation monitoring computing device, the delivery of energy to the tissue region based on the comparison.

19. The method as set forth in claim 18 wherein the one or more parameters comprise one or more tissue ablation waveforms.

20. The method as set forth in claim 18 wherein the one or more parameters are input by a user.

21. The method as set forth in claim 17 wherein the energy source comprises a radiofrequency energy source.

22. The method as set forth in claim 17 wherein the measuring device measures an electrical characteristic of the tissue region.

23. The method as set forth in claim 22 wherein the electrical characteristic comprises one of current, voltage, forward power, reverse power, phase angle, or impedance.

24. The method as set forth in claim 17 wherein the measuring device measures a physiological characteristic of the tissue region.

25. The method as set forth in claim 24 wherein the physiological characteristic comprises one or more of an impedance, a temperature, a pressure, a composition, or an elasticity.

26. The method as set forth in claim 17 wherein the measuring device measures a visual characteristic of the tissue region.

27. The method as set forth in claim 26 wherein the measuring device comprises one of intravascular ultrasound, optical coherence tomography, optical coherence reflectometry, or angiography.

28. The method as set forth in claim 17 wherein the adjusting the delivery of energy to the tissue region based on the comparison further comprises terminating the energy delivery when the one or more items of data from the measuring device exceed a threshold value.

29. The method as set forth in claim 17 wherein the one or more items of data comprises a voltage waveform and further wherein the pre-plasma phase is indicated by a peak voltage measurement of the voltage waveform, the plasma phase is indicated by a decrease in the voltage measurement of the voltage waveform, and the channel phase is indicated by a further decrease in the voltage measurement of the voltage waveform.

30. The method as set forth in claim 17 wherein the one or more items of data comprises a current waveform and further wherein the pre-plasma phase is indicated by a minimum current measurement of the current waveform, the plasma phase is indicated by an increase in the current measurement of the current waveform, and the channel phase is indicated by a further increase in the current measurement of the current waveform.

31. The method as set forth in claim 17 wherein the adjusting the delivery of energy to the tissue region further comprises adjusting the delivery of energy to minimize treatment time.

32. The method as set forth in claim 17 wherein the adjusting the delivery of energy to the tissue region further comprises adjusting the delivery of energy to minimize thermal effects on the tissue region.

Assignments (2)
CHANGE OF NAME Recorded Jan 31, 2019
From: RETROVASCULAR, INC.
To: ASAHI MEDICAL TECHNOLOGIES, INC.
Reel/Frame 048211/0124 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2014
From: OGATA, WAYNE; GU, XIANG IAN; MEYER, STEVEN; YAVARI, ALIREZA
To: RETROVASCULAR, INC.
Reel/Frame 032943/0359 →
Continuity (2)
Provisional Application 61800886 · Mar 15, 2013
Related Publication 20140309632A1 · Oct 16, 2014